Key Points
- CFO Balaji Gandhi sold 3,829 shares on March 25 at $11.26 for a total of $43,114.54, reducing his stake by 2.54% to 146,740 shares valued at about $1.65 million.
- The March sale continues a pattern of insider disposals, including 8,009 shares at $17.01 on Jan 8, 4,687 shares at $16.36 on Jan 16 and 975 shares at $16.38 on Jan 15, signaling ongoing insider selling.
- Phreesia trades near $11 with a 50-day/200-day moving average of $12.61/$17.83 and a market cap around $660.5M; analysts carry a consensus "Moderate Buy" with an average target of $28.65 amid mixed price-target revisions.
Phreesia, Inc. (NYSE:PHR - Get Free Report) CFO Balaji Gandhi sold 3,829 shares of Phreesia stock in a transaction on Wednesday, March 25th. The stock was sold at an average price of $11.26, for a total transaction of $43,114.54. Following the sale, the chief financial officer owned 146,740 shares of the company's stock, valued at $1,652,292.40. The trade was a 2.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Balaji Gandhi also recently made the following trade(s):
- On Friday, January 16th, Balaji Gandhi sold 4,687 shares of Phreesia stock. The shares were sold at an average price of $16.36, for a total transaction of $76,679.32.
- On Thursday, January 15th, Balaji Gandhi sold 975 shares of Phreesia stock. The shares were sold at an average price of $16.38, for a total value of $15,970.50.
- On Thursday, January 8th, Balaji Gandhi sold 8,009 shares of Phreesia stock. The stock was sold at an average price of $17.01, for a total value of $136,233.09.
Phreesia Stock Performance
Shares of PHR stock opened at $10.96 on Friday. The business has a fifty day moving average of $12.61 and a 200 day moving average of $17.83. Phreesia, Inc. has a 1 year low of $10.75 and a 1 year high of $32.76. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.44 and a quick ratio of 2.44. The firm has a market capitalization of $660.54 million, a price-to-earnings ratio of -109.55 and a beta of 0.67.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on PHR. Truist Financial set a $24.00 price objective on Phreesia in a research note on Thursday, January 8th. Robert W. Baird cut their price target on shares of Phreesia from $31.00 to $25.00 and set an "outperform" rating on the stock in a report on Wednesday, December 10th. Royal Bank Of Canada began coverage on shares of Phreesia in a research report on Friday, January 9th. They set a "moderate buy" rating and a $26.00 price target for the company. Wells Fargo & Company decreased their price objective on shares of Phreesia from $30.00 to $25.00 and set an "overweight" rating for the company in a research note on Thursday. Finally, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Phreesia in a report on Wednesday, January 28th. Seventeen investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $28.65.
Read Our Latest Stock Analysis on PHR
Institutional Trading of Phreesia
Hedge funds have recently modified their holdings of the stock. Federated Hermes Inc. purchased a new stake in shares of Phreesia in the third quarter valued at approximately $32,000. Van ECK Associates Corp lifted its position in shares of Phreesia by 78.7% during the 4th quarter. Van ECK Associates Corp now owns 2,502 shares of the company's stock valued at $42,000 after buying an additional 1,102 shares in the last quarter. Asset Management One Co. Ltd. purchased a new position in shares of Phreesia during the 3rd quarter valued at approximately $45,000. Rockefeller Capital Management L.P. grew its stake in Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company's stock valued at $47,000 after acquiring an additional 2,149 shares during the period. Finally, KBC Group NV increased its holdings in Phreesia by 83.4% in the 4th quarter. KBC Group NV now owns 3,449 shares of the company's stock worth $58,000 after acquiring an additional 1,568 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company's stock.
About Phreesia
(
Get Free Report)
Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company's cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.
Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
